QuidelOrtho Corp. Stock Plummets to New 52-Week Low at $14.00

QuidelOrtho Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 14.00 on April 9, 2026. This significant decline reflects a challenging year for the company, which has seen its stock price plummet by 65.59% over the past year, contrasting sharply with the S&P 500's performance of 25.06% during the same period. The company's financial metrics indicate ongoing difficulties, with a debt-equity ratio of 1.31 and a return on equity of -7.95%. QuidelOrtho has reported negative results for 12 consecutive quarters, highlighting persistent operational struggles. The stock's price-to-book ratio stands at 0.63, suggesting that it is trading below its book value. Additionally, the company has not offered any dividends, maintaining a yield of 0.00%. With a market capitalization of USD 1,202 million, QuidelOrtho's performance has consistently lagged behind industry benchmarks, raising concerns about its market position and future viability. The stock's previous 52-week high was USD 38.99, underscoring the extent of its recent decline.